Ifosfamide in the Treatment of Relapsed Lymphoma

Publisher： Karger

E-ISSN： 2296-5262|21|2|26-29

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.2, 1998-06, pp. : 26-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 4, 2014-04 ,pp. : 579-586

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support for the Treatment of Refractory or Relapsed Small-Cell Lung Cancer

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 105-109

Karger

Access to resources Recommend Favorite

Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: A children's oncology group report

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 1, 2015-01 ,pp. : 60-64

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment of relapsed anaplastic large cell lymphoma with vinblastine monotherapy and allo‐HSCT with reduced intensity conditioning regimen

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 4, 2015-08 ,pp. : 791-794

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II trial of ofatumumab plus ESHAP (O‐ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first‐line chemotherapy

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 174, Iss. 6, 2016-09 ,pp. : 859-867

John Wiley & Sons Inc

Access to resources Recommend Favorite